Sign in
CompletedNo phase

High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB

Key facts

Who runs it
Tomsk National Research Medical Center of the Russian Academy of Sciences
Where
Russia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
74 people enrolled
Started
17 Nov 2023
Ended
6 Feb 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Sham treatment
  • 200- ppm NO
Record updated
26 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (18)Hide the full registry criteria

Who can take part

  • Cardiac surgery with CPB at current hospitalization
  • Age > 18 years
  • Signed informed consent
  • The presence of at least one risk factor for the development of postoperative NP (CPB time ≥ 96 minutes and/or mechanical ventilation ≥ 14 hours and/or atrial fibrillation before surgery)

Who cannot take part

  • Emergency surgery
  • Acute coronary syndrome 30 days before surgery
  • Surgery for active infective endocarditis requiring antibiotic therapy
  • Taking antibacterial drugs for 14 days preceding surgery
  • Potentially dialysis-dependent stage 2 and higher acute kidney injury (according to KDIGO) in the early postoperative period (the criteria for potentially dialysis-dependent acute kidney injury will include patients with stage 2 acute kidney injury and: oliguria against the background of normo-hypervolemia and resistance to loop diuretics and/or oliguria against the background of conducting infusion therapy due to hypovolemia and resistance to loop diuretics)
  • Patient's participation in another clinical trial at the time of screening or within the previous 3 months
  • Concomitant pulmonary disease with the need for respiratory support before surgery
  • Diagnosed infectious process of another localization (surgical site infection (SSI), acute and chronic urinary tract infection (active), catheter-related bloodstream infection, peritonitis, etc.)
  • Other complications of the postoperative period (pneumothorax requiring pleural drainage, perioperative myocardial infarction accompanied by pulmonary edema, shock of any etiology during the current hospitalization)
  • History of malignancy or other irreversible diseases/conditions with a 6-month mortality rate >50%
  • Presence of HIV infection
  • Continued mechanical ventilation
  • Delirium
  • Presence of tracheostomy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The primary aim of this single-center, prospective, randomized, controlled, pilot study is to test the hypothesis that inhalation of NO 200 ppm prevents the development of nosocomial pneumonia in patients at risk after cardiac surgery with CPB. The study is interventional. Examination and treatment of patients is carried out in accordance with the approved standards of medical care for the relevant diseases. During the study, no experimental or unregistered (not approved for use) medical or diagnostic procedures in the territory of the Russian Federation will be carried out. The study includes patients admitted to the Cardiac Surgery Department of Cardiology Research Institute of Tomsk National Research Medical Center for elective surgery with CPB.

The 2 groups in the trial

  • Control groupExisting treatment, for comparison

    Oxygen-air mixture without NO after extubation within 5 days after surgery 2 times a day for 30 min

    Treatment: Sham treatment

  • 200 ppmTreatment being tested

    NO will be supplemented at 200-ppm concentration after extubation within 5 days after surgery 2 times a day for 30 min

    Treatment: 200- ppm NO

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With Cardiopulmonary Bypass
Record updated
26 June 2026